NEWARK, N.J., Oct. 12, 2010 (GLOBE NEWSWIRE) -- BioNeutral Group, Inc. (OTCBB:BONU), a specialty chemical technology-based life science company, announced today that it has retained James T. Harrington as a business consultant and appointed him to the company's Advisory Board. Mr. Harrington adds significant expertise in the environmental sector, as well as knowledge and legal background which will be invaluable in assisting BioNeutral in achieving its business goals, especially in developing business in the industrial sector.
Mr. Harrington has more than four decades of experience as a practicing environmental lawyer. He is partner emeritus of the prestigious Chicago-based law firm of McGuire Woods LLP. and served as partner with the Chicago law firms of Ross & Hardies and Rooks, Pitts and Poust. James Harrington has represented major U.S. manufacturing companies in state and federal enforcement action and litigated at the trial and appellate levels. He has an extensive background in federal, state and local regulatory development and judicial review with an emphasis on air pollution and state implementation plans, federal effluent guidelines, pretreatment standards, and state regulatory development. A major portion of his time has been spent counseling and representing clients on air, water, and solid and hazardous waste regulations and compliance issues. He has expressed the impact of environmental regulations upon corporate valuation, real estate and operational transactions to legislatures, rule making agencies and the courts. He assisted various industries and industrial groups in developing state and federal regulations regarding air, water and groundwater remediation and has counseled on all aspects of environmental law, compliance and permitting policy and strategy.
Throughout his career, Mr. Harrington has represented major U.S. industries including: Iron and Steel, Petroleum Refining, Chemicals, Aluminum, Foundries, Electrical Generation – coal-fired and waste to energy, Plastics, Paint, Metals, Coating and General Manufacturing. He represented the American Iron and Steel Institute in challenging and negotiating pretreatment standards. Clients within the petroleum industry included: Conoco Phillips Petroleum, Marathon Petroleum, Mobil Oil, Standard Oil of Indiana, Union Oil and the Shell Oil Company. Within the Chemical, Paint and Plastics industry he worked with the Monsanto Company, Ashland Chemical Company, Mobil Chemical, Borg Warner Plastics, GE Plastics and the Sherwin-Williams Company. In heavy industry he represented Caterpillar, the International Truck and Engine Corporation and Navistar, among others.
He was named one of the "Best Lawyers in America," Woodward/White, Inc. 2007-2008 and listed in "The International Who's Who of Environmental Lawyers." Mr. Harrington received his law degree from Notre Dame University in 1967, where served on the Board of Editors for the Notre Dame Law Review, Notre Dame Lawyer. He served as Past President of the Mid-American Legal Foundation of Chicago and Past Chairman of the Illinois Safety Council along with numerous professional affiliations. He writes and lectures on issues of environmental law and is Adjunct Professor at the Illinois Institute of Technology in the Stuart School of Business, Masters in Environmental Management Program and is Chairman of the Program Advisory Board. James Harrington also serves as Adjunct Professor of Environmental Law at Loyola Law School in Chicago.
Mr. Harrington said, "I look forward to helping BioNeutral achieve its business objectives and execute on its business plan. BioNeutral has developed a compelling technology platform, featuring two exciting product families. I believe these technologies address large and mostly unmet issues and I look forward to contributing my expertise."
Stephen J. Browand, Chairman and CEO of BioNeutral Group, Inc., said, "Adding a respected and well-known attorney like Mr. Harrington as a consultant and adviser will accelerate our business development efforts and help us to position BioNeutral appropriately with potential industrial customers. He brings tremendous contacts within our target markets and a lifetime of experience with environmental issues. We are very pleased to have Jim working with us and enthusiastically welcome him to the BioNeutral team."
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene and Ogiene, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene™ brand have been submitted to the EPA for approval for sale in the United States and has already been approved for sale in Germany and is permitted to be sold in the UK, France and Sweden. For more information, see www.bioneutralgroup.com
Forward-Looking Statements
This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.
CONTACT: Stern & Co. PR/Media Relations: Richard Stern 212-888-0044 richstern@sternco.com Hayden IR Investor Relations: Brett Maas 646/536-7331 brett@haydenir.com BioNeutral Group Inc. Stephen J. Browand, President and CEO 973-286-2899 steve@bioneutralgroup.com